Please click here for an updated version of this story.
NEW YORK, July 19 - Accelrys today said it has opened its new European headquarters.
The new base, in Cambridge, UK, will consolidate staff from Accelrys' facilities already in that city as well as in Leeds and Oxford. It has been devised to provide services, support, and training to European customers, the company said.
According to Accelrys, a unit of drug discoverer Pharmacopoeia, the 42,000-square-foot space will also be home to the firm's European product-development staff, sales and marketing departments, finance, and administration.
Additionally, Accelrys will use a portion of the space to hold scientific conferences and seminars, the company said.